This is a Validated Antibody Database (VAD) review about human deleted in breast cancer 1, based on 12 published articles (read how Labome selects the articles), using deleted in breast cancer 1 antibody in all methods. It is aimed to help Labome visitors find the most suited deleted in breast cancer 1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
deleted in breast cancer 1 synonym: DBC-1; DBC1; KIAA1967; NET35; p30 DBC; p30DBC; cell cycle and apoptosis regulator protein 2; cell division cycle and apoptosis regulator protein 2; deleted in breast cancer 1; p30 DBC protein

Bethyl
rabbit polyclonal
  • immunoprecipitation; human; fig 4
  • western blot; human; fig 4
Bethyl deleted in breast cancer 1 antibody (Bethyl Labrotories, A300-432A) was used in immunoprecipitation on human samples (fig 4) and in western blot on human samples (fig 4). Am J Cancer Res (2016) ncbi
rabbit polyclonal
  • immunohistochemistry; human; 1:100; fig 2
Bethyl deleted in breast cancer 1 antibody (Bethyl Lab, IHC-00135) was used in immunohistochemistry on human samples at 1:100 (fig 2). Pathol Res Pract (2016) ncbi
goat polyclonal
  • western blot; human; 0.2 ug/ml
In order to develop reagents to study RNA binding proteins, Bethyl deleted in breast cancer 1 antibody (Bethyl, A303-942A) was used in western blot on human samples at 0.2 ug/ml. Mol Cell (2016) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; fig 1
Bethyl deleted in breast cancer 1 antibody (Bethyl Laboratories, IHC-00135) was used in immunohistochemistry - paraffin section on human samples (fig 1). Int J Clin Exp Pathol (2015) ncbi
rabbit polyclonal
  • immunoprecipitation; human; fig s1
In order to determine the role of DBC1 sumoylation in p53-mediated apoptosis, Bethyl deleted in breast cancer 1 antibody (Bethyl, A300-434A) was used in immunoprecipitation on human samples (fig s1). Nat Commun (2014) ncbi
rabbit polyclonal
  • immunoprecipitation; human; fig 4
  • western blot; human; fig 1
Bethyl deleted in breast cancer 1 antibody (Bethyl, A300?C434A) was used in immunoprecipitation on human samples (fig 4) and in western blot on human samples (fig 1). Nucleic Acids Res (2014) ncbi
rabbit polyclonal
  • western blot; human; fig 1c
Bethyl deleted in breast cancer 1 antibody (Bethyl, A300-432A) was used in western blot on human samples (fig 1c). Am J Cancer Res (2014) ncbi
rabbit polyclonal
  • immunoprecipitation; mouse
  • western blot; mouse; fig 4
  • immunoprecipitation; human
Bethyl deleted in breast cancer 1 antibody (Bethyl, A300-432A) was used in immunoprecipitation on mouse samples , in western blot on mouse samples (fig 4) and in immunoprecipitation on human samples . Exp Neurol (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; mouse; fig 3
Bethyl deleted in breast cancer 1 antibody (Bethyl, IHC00135-1) was used in immunocytochemistry on mouse samples (fig 3). Exp Neurol (2014) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; fig 1
Bethyl deleted in breast cancer 1 antibody (Bethyl, IHC-00135) was used in immunohistochemistry - paraffin section on human samples (fig 1). Int J Clin Oncol (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (H-2)
  • western blot; human
Santa Cruz Biotechnology deleted in breast cancer 1 antibody (Santa Cruz Biotechnology, sc-166733) was used in western blot on human samples . Am J Physiol Endocrinol Metab (2015) ncbi
mouse monoclonal (H-2)
  • immunoprecipitation; human; fig s1
  • immunocytochemistry; human; fig s5
  • western blot; human; 1:1000; fig s1
In order to determine the role of DBC1 sumoylation in p53-mediated apoptosis, Santa Cruz Biotechnology deleted in breast cancer 1 antibody (Santa Cruz Biotechnology, clone H-2) was used in immunoprecipitation on human samples (fig s1), in immunocytochemistry on human samples (fig s5) and in western blot on human samples at 1:1000 (fig s1). Nat Commun (2014) ncbi
Cell Signaling Technology
mouse monoclonal (3G4)
  • immunoprecipitation; human; 1:1000; loading ...; fig 4g
Cell Signaling Technology deleted in breast cancer 1 antibody (Cell Signaling Technology, 5857S) was used in immunoprecipitation on human samples at 1:1000 (fig 4g). Mol Cell (2017) ncbi
mouse monoclonal (3G4)
  • immunoprecipitation; human
  • immunocytochemistry; human
Cell Signaling Technology deleted in breast cancer 1 antibody (Cell Signaling, 5857) was used in immunoprecipitation on human samples and in immunocytochemistry on human samples . J Steroid Biochem Mol Biol (2015) ncbi
mouse monoclonal (3G4)
  • immunoprecipitation; human; fig 4
  • western blot; human; fig 1
Cell Signaling Technology deleted in breast cancer 1 antibody (Cell Signaling Technology, 5857) was used in immunoprecipitation on human samples (fig 4) and in western blot on human samples (fig 1). Nucleic Acids Res (2014) ncbi
Articles Reviewed
  1. Sakamaki J, Wilkinson S, Hahn M, Tasdemir N, O Prey J, Clark W, et al. Bromodomain Protein BRD4 Is a Transcriptional Repressor of Autophagy and Lysosomal Function. Mol Cell. 2017;66:517-532.e9 pubmed publisher
  2. Liu X, Ehmed E, Li B, Dou J, Qiao X, Jiang W, et al. Breast cancer metastasis suppressor 1 modulates SIRT1-dependent p53 deacetylation through interacting with DBC1. Am J Cancer Res. 2016;6:1441-9 pubmed
  3. Ha S, Kim J, Yang J, Bae H, Cho H, Park C. Expression of DBC1 is associated with poor prognosis in hepatitis virus-related hepatocellular carcinoma. Pathol Res Pract. 2016;212:616-21 pubmed publisher
  4. Sundararaman B, Zhan L, Blue S, Stanton R, Elkins K, Olson S, et al. Resources for the Comprehensive Discovery of Functional RNA Elements. Mol Cell. 2016;61:903-13 pubmed publisher
  5. Won K, Cho H, Kim G, Lim S, Bae G, Lim J, et al. High DBC1 (CCAR2) expression in gallbladder carcinoma is associated with favorable clinicopathological factors. Int J Clin Exp Pathol. 2015;8:11440-5 pubmed
  6. Sakurabashi A, Wada Hiraike O, Hirano M, Fu H, Isono W, Fukuda T, et al. CCAR2 negatively regulates nuclear receptor LXRα by competing with SIRT1 deacetylase. J Steroid Biochem Mol Biol. 2015;149:80-8 pubmed publisher
  7. Moreno Navarrete J, Moreno M, Vidal M, Ortega F, Serrano M, Xifra G, et al. Deleted in breast cancer 1 plays a functional role in adipocyte differentiation. Am J Physiol Endocrinol Metab. 2015;308:E554-61 pubmed publisher
  8. Park J, Lee S, Yang S, Yoo H, Park J, Seong M, et al. Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage. Nat Commun. 2014;5:5483 pubmed publisher
  9. Magni M, Ruscica V, Buscemi G, Kim J, Nachimuthu B, Fontanella E, et al. Chk2 and REGγ-dependent DBC1 regulation in DNA damage induced apoptosis. Nucleic Acids Res. 2014;42:13150-60 pubmed publisher
  10. Lau A, Liu P, Inuzuka H, Gao D. SIRT1 phosphorylation by AMP-activated protein kinase regulates p53 acetylation. Am J Cancer Res. 2014;4:245-55 pubmed
  11. Calliari A, Bobba N, Escande C, Chini E. Resveratrol delays Wallerian degeneration in a NAD(+) and DBC1 dependent manner. Exp Neurol. 2014;251:91-100 pubmed publisher
  12. Zhang Y, Gu Y, Sha S, Kong X, Zhu H, Xu B, et al. DBC1 is over-expressed and associated with poor prognosis in colorectal cancer. Int J Clin Oncol. 2014;19:106-12 pubmed publisher